Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status

BACKGROUND: Subjective cognitive decline (SCD) is a target for Alzheimer’s disease prediction. Plasma amyloid-beta oligomer (AβO), the pathogenic form of Aβ in blood, has recently been proposed as a novel blood-based biomarker of AD prediction by representing brain Aβ deposition. The relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Keun You, Park, Jaesub, Jeong, Yong Hyu, Kim, Hyun Jeong, Lee, Eun, Park, Jin Young, Kim, Eosu, Kim, Woo Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632136/
https://www.ncbi.nlm.nih.gov/pubmed/36324157
http://dx.doi.org/10.1186/s13195-022-01104-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632136/
https://www.ncbi.nlm.nih.gov/pubmed/36324157
http://dx.doi.org/10.1186/s13195-022-01104-6

Ejemplares similares